The patented formulation showed activity against oral cancer cells, researchers said, but further preclinical studies are needed to establish its safety and efficacy.
The Drugs Consultative Committee has sought the DGHS opinion and data on Merbromin's manufacture and use before deciding on its continued inclusion under Schedule K
The Drugs Consultative Committee has sought a detailed proposal from Rajasthan amid concerns that machinery from closed pharma units could be used to make spurious drugs
A Bench of Justices Vikram Nath and Sandeep Mehta asked the Centre why the maximum retail price (MRP) of essential medicines such as cancer drugs could not be capped at 16 per cent
PFRDA's NPS Swasthya combines healthcare withdrawals with a super top-up cover, while Irdai proposes tighter commissions and expense limits to curb mis-selling and lower distribution costs
Proposed 350-bed facility in UP to strengthen Global Health's footprint across Delhi-NCR healthcare market
World Heart Day 2026: A report by digital health benefits platform ekincare found that 58.5% of employees under 35 had at least one flagged cardiovascular risk marker in 2026 year-to-date data
Dr Bhawna Sirohi said high costs, limited access to genomic testing and expensive targeted drugs remain barriers to precision oncology, despite its potential to improve cancer treatment
India has directed states to crack down on the illegal sale of nicotine pouches, citing health risks and increased availability through online and offline channels.
Medtech manufacturers and private hospitals back trade margin rationalisation but seek a fact-based approach that accounts for category-specific costs and procurement structures
A new review examines the potential of immune modulation and regenerative medicine for hair loss, but experts say no clinically validated 'hair vaccine' exists yet
Proposed rules could restrict sales of high-fat and high-sugar foods near India's 1.5 million schools, adding pressure on global food and beverage companies
India reiterated its commitment to eliminating hepatitis B and C as public health threats by 2030, with a focus on prevention, screening, diagnosis, treatment and care
Drug regulator asks healthcare professionals and pharmacists to discourage indiscriminate use of NSAIDs and antibiotics, citing risks of kidney damage and CKD
AI can accelerate health research, but the WHO warns that existing oversight may not fully address emerging risks involving data, bias and accountability
Respiratory infections can share similar symptoms, making them difficult to distinguish
Mumbai-based Vytalyou has raised Rs 8-10 crore at a valuation of around Rs 33 crore to expand its network in Mumbai and enter other major Indian cities in 2027
Pharmarack data show anti-bacterial unit sales falling since 2023; experts say lower volumes alone do not indicate more appropriate antibiotic use
Experts said growing evidence suggests that genetic and epigenetic factors may influence a woman's susceptibility to the condition
Grouping eyes more collaboration on treatment TB, NCD and mental health